News
-
BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
-
BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
-
CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
-
LNA SANTE : 2025 Annual Results
-
Strong investment performance and active roll-out of our strategy
-
Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
-
Challenger RC Resource Upgrade Drilling Complete
-
Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
-
Gemina Laboratories Ltd. Announces Delisting from the CSE
-
Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
-
Delivery Hero reports adj EBITDA up 30% in 2025, as Quick Commerce and key markets gain momentum
-
Berentzen-Gruppe Aktiengesellschaft publishes its 2025 Annual Report – Berentzen Group achieves significant consolidated profit
-
Heidelberg Pharma Announces Financial Figures and Reports on Business Performance in 2025 and Outlook for 2026
-
Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children
-
EDAG Group: Market uncertainty and delayed awarding of projects shape FY 2025 – Strategic measures accelerated to restore sustainable growth and competitiveness